跳至主要内容
临床试验/NL-OMON53694
NL-OMON53694招募中不适用

Prospective randomized multi-center controlled clinical investigation comparing PFO outcomes of the Occlutech Flex II PFO Occluder to standard of care PFO occlusion. - Occluflex

Occlutech US LLC0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Subjects with a PFO and cryptogenic stroke:
  • PFO defined as visualization of microbubbles (during TEE) in the left atrium
  • within three cardiac cycles of right atrial opacification at rest and/or with
  • Cryptogenic stroke defined as a stroke of unknown cause.
  • Stroke defined as an acute focal neurological deficit, presumed to be due to
  • focal ischemia, and either:
  • o Symptoms persisting >=24 hours, or
  • o Symptoms persisting <24 hours with MR or CT findings of a new,
  • neuroanatomically relevant, cerebral infarct.

排除标准

  • Age <18 years
  • MI or unstable angina within 6 months
  • Mitral or aortic valve stenosis or severe regurgitation
  • LVEF <35%
  • Uncontrolled hypertension or diabetes mellitus despite medications
  • Subjects contraindicated for aspirin or clopidogrel
  • Subjects not able to discontinue anticoagulation
  • Qualifying stroke with Modified Rankin score >3
  • Anatomy in which the device would interfere with intracardiac or vascular
  • Life expectancy < 2 years
  • Exclusion for patients with known causes of ischemic stroke:
  • Atrial fibrillation/atrial flutter (chronic or intermittent)
  • LV aneurysm, intracardiac thrombus, or tumor
  • Mitral or aortic valve vegetation or prosthesis
  • Aortic arch plaques protruding >4 mm into the lumen
  • Atherosclerosis or arteriopathy of intra- or extracranial vessels with >50%
  • diameter stenosis in the artery supplying the infarcted territory
  • Another cause of right-to-left shunting (e.g., an ASD or a fenestrated atrial
  • Presence of an arterial hypercoagulable state:
  • o Lupus anticoagulant,
  • o anticardiolipin Abs,
  • o hyperhomocysteinemia,
  • o Cancer-related hypercoagulability.
  • Lacunar infarct probably due to intrinsic small vessel as the qualifying
  • event, defined as an ischemic stroke in the distribution of a single, small
  • deep penetrating vessel in a patient with any of the following:
  • o A history of hypertension (except in the first week post stroke)
  • o A history of diabetes mellitus
  • o Age >=50 years
  • o MRI or CT with leukoaraiosis greater than symmetric, well-defined
  • periventricular caps, or bands (European Task Force on Age-Related White Matter
  • Changes rating scale score >0)
  • Arterial dissection as the qualifying event

研究者

发起方
Occlutech US LLC

相似试验